CD274 and neoplasm: by using the co-culture system, we further found that Bafetinib enhanced the killing effect of T cells on tumor cells, which suggests that Bafetinib-triggered PD-L1 suppression is sufficient to achieve anti-tumor immunity (Figure 4H).